Lineage Cell Therapeutics, Inc. House Periodic Transaction Reports: Other
Transactions reported by Members of the U.S. House of Representatives on Periodic Transaction Reports, from the Clerk of the House. Amounts are the ranges filed. Values are as filed; nothing is estimated.
- 2024-01-02: Member Hon. Anna Paulina Luna; Owner Filer; Asset Lineage Cell Therapeutics Inc.
| Transaction date | Member | Owner | Asset | Transaction type | Notification date | Amount | Filed |
|---|---|---|---|---|---|---|---|
| 2024-01-02 | Hon. Anna Paulina Luna FL13 | Filer | Lineage Cell Therapeutics Inc | 2024-01-04 | $1,001 - $15,000 | 2024-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |